{"text_format":"1","workbook":"xlsx","n_sheets":1,"sheets":["ND_new_wac"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":0,"defined_names":0,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900"}

{"sheet":"ND_new_wac","index":0,"n_rows":2,"n_cols":9,"rows_kept":2,"cut":false,"hidden":false,"merged":[]}
["NDC11","NDC Description","Trade or Generic","Trade Name","Generic Name","Manufacturer","Date Introduced","WAC","Reason for Exceeding Threshold"]
[69448001463,"1 SYRINGE in 1 CARTON (69448-014-63) > .37 g in 1 SYRINGE","T","Camcevi","LEUPROLIDE","Accord BioPharma, Inc.","2022-04-05",3900,"Accord Biopharma has priced Camcevi using factors that are confidential in nature and can not be publicly released. Please note that Camcevi is a specialty product, and as so, is reasonably priced in excess of the threshold in which Medicare Part D considers a specialty drug."]